Trial intelligence / Profile preview

DMT for Experimentally Induced Pain in Healthy Participants

NCT06180759Phase 1Completed

Sponsor
University Hospital Basel
Start
Jan 2025
Primary completion
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of DMT in pain (3 arms), sponsored by University Hospital Basel. Primary endpoint: Numeric Rating Scale scores at 55 minutes. Started Jan 2025; status: completed.

02

Drugs

DMT
03

Conditions

pain

Beyond the preview

Go deeper on NCT06180759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06180759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call